增加兰巴链抗体的开发能力:设计以赋予蛋白质L结合活性及其后果
Bianca Prado-Costa1, Gaëlle Dupeyrol2, Fanny Boursin2
1Programa de Pós-Graduação em Microbiologia, Parasitologia e Patologia - Departamento de Patologia Básica, Universidade Federal do Paraná (UFPR), CEP 81531-980 Curitiba, PR, Brazil; UMR 1282 ISP, INRAE, Université de Tours, Team BioMAP, F-37200 Tours, France.
International journal of biological macromolecules
|May 14, 2025
概括
这项研究设计了lambda抗体来结合蛋白L,提高了它们用于生物技术应用的可开发性. 优化的碎片显示出更好的热稳定性和保留抗原结合,为新的治疗和诊断工具铺平了道路.
科学领域:
- 生物技术和蛋白质工程 生物技术和蛋白质工程
- 免疫学和抗体治疗疗法
背景情况:
- 蛋白L (PpL) 对于抗体净化至关重要,它与可变光链结合.
- 蛋白L的一个局限性是它无法结合兰巴链抗体,从而阻碍了它们的发展能力.
- 工程兰巴抗体对于扩大它们在生物技术中的实用性至关重要.
研究的目的:
- 为了设计具有蛋白质L结合能力的兰巴链抗体.
- 为了提高兰巴抗体的开发能力,使用抗阿坎他梅巴IgG mAb3作为模板.
- 为了增强热稳定性和保持工程抗体碎片的抗原识别.
主要方法:
- 来自mAb3.3的重组单链可变片段 (scFvs) 的构造和表达.
- 使用蛋白质L亲和力净化,ELISA和西部抹杀评估蛋白质L结合.
- 通过化温度测量和抗原反应性分析评估热稳定性.
主要成果:
- 产生了四种功能性mAb3衍生的scFvs,其中两种显示蛋白L结合.
- 一种蛋白质L结合scFv表现出增强的热稳定性,将化温度提高8.7°C至67.2°C,具有高的生产产量.
- 工程化scFvs和衍生出的小体和scFv-Fc片段保留了抗原结合和蛋白L相互作用配置文件.
结论:
- 兰巴达链抗体可以通过向突变来设计用于蛋白质L结合.
- 这种工程方法显著提高了用于治疗和诊断目的的抗体开发能力.
- 这项研究为优化生物技术应用中的兰巴抗体提供了一个可行的策略.
相关概念视频
Ligand Binding and Linkage
4.7K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.7K
Antibody Structure
58.7K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
58.7K
Ligand Binding Sites
12.6K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.6K


